<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neurological or <z:e sem="disease" ids="C0852553" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychiatric symptoms</z:e> are present in 60% of the cases with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Direct lesions of <z:mp ids='MP_0008912'>nervous</z:mp> system are associated with the presence of antibodies, <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, <z:mp ids='MP_0005048'>thrombosis</z:mp> and impairments mediated by cytokines </plain></SENT>
<SENT sid="2" pm="."><plain>Damages caused by injuries of other organs or those due to therapy are known as indirect causes </plain></SENT>
<SENT sid="3" pm="."><plain>In the complex pathogenesis the primary cause is neuronal dysfunction mediated by autoantibodies, vasculopathia and coagulopathia </plain></SENT>
<SENT sid="4" pm="."><plain>Until now, more than 20 antibodies have been identified in association with damages of the <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="5" pm="."><plain>These antibodies may impair neurons or astrocytes and may promote thrombotic processes in vessels of the brain </plain></SENT>
<SENT sid="6" pm="."><plain>Activation of endothelial cells and disturbance of blood-brain barrier are also pathogenic factors </plain></SENT>
<SENT sid="7" pm="."><plain>In patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> the most frequent psychiatric manifestations are <z:e sem="disease" ids="C0679479" disease_type="Disease or Syndrome" abbrv="">organic psychosyndrome</z:e>, particularly deterioration of cognitive functions, and <z:hpo ids='HP_0000716'>depression</z:hpo>, while the most common neurological syndromes are <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> and <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In the pathogenesis of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> Î²2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I plays the most important role; binding to its antibody the complex may interact with cells and modify haemostatic actions </plain></SENT>
<SENT sid="9" pm="."><plain>The most frequent neurological manifestations of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> are <z:hpo ids='HP_0002315'>headache</z:hpo> and <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>